Suppr超能文献

金黄色葡萄球菌菌血症的特征及早期和晚期死亡率的预测因素

Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality.

作者信息

Bassetti Matteo, Peghin Maddalena, Trecarichi Enrico Maria, Carnelutti Alessia, Righi Elda, Del Giacomo Paola, Ansaldi Filippo, Trucchi Cecilia, Alicino Cristiano, Cauda Roberto, Sartor Assunta, Spanu Teresa, Scarparo Claudio, Tumbarello Mario

机构信息

Infectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.

Institute of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

PLoS One. 2017 Feb 2;12(2):e0170236. doi: 10.1371/journal.pone.0170236. eCollection 2017.

Abstract

We aimed to describe the characteristics of patients with Staphylococcus aureus bacteremia and to evaluate the risk factors associated with early (7-day) and late (30-day) mortality. We performed an observational study including all consecutive episodes of Staphylococcus aureus bacteremia diagnosed at two Italian university hospitals during 2010-2014. A total of 337 patients were included. Mean age was 69 years (range, 57-78) and 65% were males. Methicillin-resistant S. aureus (MRSA) was identified in 132/337 (39%)cases. Overall 7- and 30-day mortality were 13% and 26%, respectively. Early mortality was associated with increased Charlson scores (OR 1.3, 95% CI 1.1-1.5), MRSA bacteremia (OR 3.2, 95% CI 1.4-8.1), presentation with septic shock (OR 13.5, 95% CI 5.4-36.4), and occurrence of endocarditis (OR 4.5, 95%CI 1.4-14.6). Similar risk factors were identified for late mortality, including increased Charlson scores (OR 1.2, 95% CI 1.1-1.4), MRSA bacteremia (OR 2.1, 95% CI 1.2-3.9), presentation with septic shock (OR 4, 95%CI 1.7-9.7), occurrence of endocarditis (OR 3.8, 95% CI 1.4-10.2) as well as Child C cirrhosis (OR 3.9, 95% CI 1.1-14.4) and primary bacteremia (OR 2.5, 95%CI 1.3-5). Infectious disease consultation resulted in better outcomes both at 7 (OR 0.1, 95% CI 0.05-0.4) and at 30 days (OR 0.4, 95% CI 0.2-0.7). In conclusion, our study highlighted high rates of MRSA infection in nosocomial Staphylococcus aureus bacteremia. Multiple comorbidities, disease severity and methicillin-resistance are key factors for early and late mortality in this group. In patients with Staphylococcus aureus bacteremia, infectious disease consultation remains a valuable tool to improve clinical outcome.

摘要

我们旨在描述金黄色葡萄球菌菌血症患者的特征,并评估与早期(7天)和晚期(30天)死亡率相关的危险因素。我们进行了一项观察性研究,纳入了2010年至2014年期间在两家意大利大学医院诊断出的所有连续性金黄色葡萄球菌菌血症病例。共纳入337例患者。平均年龄为69岁(范围57 - 78岁),65%为男性。在132/337(39%)的病例中鉴定出耐甲氧西林金黄色葡萄球菌(MRSA)。总体7天和30天死亡率分别为13%和26%。早期死亡率与查尔森评分增加(比值比1.3,95%置信区间1.1 - 1.5)、MRSA菌血症(比值比3.2,95%置信区间1.4 - 8.1)、脓毒性休克表现(比值比13.5,95%置信区间5.4 - 36.4)以及心内膜炎的发生(比值比4.5,95%置信区间1.4 - 14.6)相关。晚期死亡率也发现了类似的危险因素,包括查尔森评分增加(比值比1.2,95%置信区间1.1 - 1.4)、MRSA菌血症(比值比2.1,95%置信区间1.2 - 3.9)、脓毒性休克表现(比值比4,95%置信区间1.7 - 9.7)、心内膜炎的发生(比值比3.8,95%置信区间1.4 - 10.2)以及Child C级肝硬化(比值比3.9,95%置信区间1.1 - 14.4)和原发性菌血症(比值比2.5,95%置信区间1.3 - 5)。感染病会诊在7天(比值比0.1,95%置信区间0.05 - 0.4)和30天(比值比0.4,95%置信区间0.2 - 0.7)时均带来更好的结果。总之,我们的研究强调了医院获得性金黄色葡萄球菌菌血症中MRSA感染的高发生率。多种合并症、疾病严重程度和耐甲氧西林是该组早期和晚期死亡率的关键因素。对于金黄色葡萄球菌菌血症患者,感染病会诊仍然是改善临床结局的重要工具。

相似文献

1
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality.
PLoS One. 2017 Feb 2;12(2):e0170236. doi: 10.1371/journal.pone.0170236. eCollection 2017.
3
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.
4
Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.
Infect Control Hosp Epidemiol. 2006 Nov;27(11):1219-25. doi: 10.1086/507924. Epub 2006 Sep 29.
6
Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults.
J Am Geriatr Soc. 2018 Jul;66(7):1284-1289. doi: 10.1111/jgs.15391. Epub 2018 Apr 17.
9
Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.

引用本文的文献

1
Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia.
Sci Rep. 2025 Aug 21;15(1):30709. doi: 10.1038/s41598-025-16137-8.
3
Risk and Distribution of Metastatic Infections by Primary Infection Focus in Bacteremia.
Open Forum Infect Dis. 2025 Jun 25;12(6):ofaf338. doi: 10.1093/ofid/ofaf338. eCollection 2025 Jun.
5
Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia.
BMC Infect Dis. 2025 Feb 18;25(1):231. doi: 10.1186/s12879-025-10620-3.
6
Risk Factors for Infection-Attributable Mortality in Patients With Bacteremia: A Competing Risk Analysis.
Open Forum Infect Dis. 2024 Dec 24;12(1):ofae734. doi: 10.1093/ofid/ofae734. eCollection 2025 Jan.
7
Bloodstream infections: mechanisms of pathogenesis and opportunities for intervention.
Nat Rev Microbiol. 2025 Apr;23(4):210-224. doi: 10.1038/s41579-024-01105-2. Epub 2024 Oct 17.
8
Female Sex and Mortality in Patients with Staphylococcus aureus Bacteremia: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2024 Feb 5;7(2):e240473. doi: 10.1001/jamanetworkopen.2024.0473.
9
Prevalence of Infective Endocarditis among Patients with Bacteraemia and Bone and Joint Infections.
Microorganisms. 2024 Feb 6;12(2):342. doi: 10.3390/microorganisms12020342.
10
Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible Bacteremia.
Antibiotics (Basel). 2023 Oct 29;12(11):1577. doi: 10.3390/antibiotics12111577.

本文引用的文献

1
Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Ann Clin Microbiol Antimicrob. 2016 Feb 9;15:7. doi: 10.1186/s12941-016-0122-8.
2
3
Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis.
J Infect. 2016 Jan;72(1):19-28. doi: 10.1016/j.jinf.2015.09.037. Epub 2015 Oct 9.
4
Evolving Epidemiology of Staphylococcus aureus Bacteremia.
Infect Control Hosp Epidemiol. 2015 Dec;36(12):1417-22. doi: 10.1017/ice.2015.213. Epub 2015 Sep 16.
7
Model for End-stage Liver Disease.
J Clin Exp Hepatol. 2013 Mar;3(1):50-60. doi: 10.1016/j.jceh.2012.11.002. Epub 2012 Dec 1.
10
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.
J Infect. 2014 Sep;69(3):226-34. doi: 10.1016/j.jinf.2014.05.004. Epub 2014 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验